ArticleJournal of thoracic disease2025
A nomogram model for predicting pneumothorax after CT-guided localization of pulmonary nodules using autologous blood and methylene blue.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The widespread use of low-dose chest computed tomography (CT) has significantly increased the early detection rate of small nodules. Existing localization methods have certain limitations. Preoperative localization using autologous blood combined with methylene blue has garnered attention due to its dual advantages. This study aims to evaluate the safety and pneumothorax risk of CT-guided preoperative localization using this technique and explore the risk factors associated with pneumothorax occurrence. Methods: This retrospective study included 112 patients who underwent CT-guided preoperative lung nodule localization using autologous blood and methylene blue between November 2019 and November 2024 at The First Hospital of Putian. Patient demographics, imaging characteristics, procedural details, and post-localization complications were collected. Logistic regression was used to analyze the independent risk factors for pneumothorax. Results: The localization success rate was 90.2%, and the pneumothorax incidence was 16.1%. Multivariate analysis identified white blood cell (WBC) count [odds ratio (OR) 1.43, 95% confidence interval (CI): 1.06-1.96, P=0.02] and the needle-tip-to-visceral-pleura distance (OR 2.36, 95% CI: 1.07-5.44, P=0.04) as independent risk factors for pneumothorax. A predictive nomogram model with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.762 was developed, demonstrating good predictive performance. Conclusions: Autologous blood combined with methylene blue is a safe and effective localization method for lung nodules. WBC count and needle-tip-to-visceral-pleura distance are independent risk factors for pneumothorax. The nomogram model provides valuable assistance for preoperative risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.